Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $43,056 - $50,346
-435 Reduced 3.35%
12,534 $1.45 Million
Q2 2023

Aug 10, 2023

SELL
$96.34 - $112.38 $69,075 - $80,576
-717 Reduced 5.24%
12,969 $1.33 Million
Q1 2023

May 04, 2023

SELL
$107.32 - $113.5 $267,226 - $282,615
-2,490 Reduced 15.39%
13,686 $1.49 Million
Q4 2022

Feb 10, 2023

BUY
$62.39 - $113.8 $84,476 - $154,085
1,354 Added 9.14%
16,176 $1.84 Million
Q3 2022

Nov 09, 2022

SELL
$58.92 - $84.67 $70,232 - $100,926
-1,192 Reduced 7.44%
14,822 $917,000
Q2 2022

Aug 16, 2022

SELL
$79.4 - $116.36 $194,053 - $284,383
-2,444 Reduced 13.24%
16,014 $1.28 Million
Q1 2022

May 10, 2022

BUY
$86.42 - $109.81 $5,617 - $7,137
65 Added 0.35%
18,458 $1.94 Million
Q4 2021

Feb 03, 2022

BUY
$98.56 - $119.91 $57,657 - $70,147
585 Added 3.29%
18,393 $1.98 Million
Q3 2021

Nov 04, 2021

BUY
$91.91 - $110.37 $28,767 - $34,545
313 Added 1.79%
17,808 $1.95 Million
Q2 2021

Aug 05, 2021

BUY
$86.24 - $95.92 $10,693 - $11,894
124 Added 0.71%
17,495 $1.64 Million
Q1 2021

Jun 02, 2021

BUY
$71.83 - $95.48 $14,078 - $18,714
196 Added 1.14%
17,371 $1.6 Million
Q4 2020

Feb 10, 2021

BUY
$67.0 - $84.39 $15,477 - $19,494
231 Added 1.36%
17,175 $1.26 Million
Q3 2020

Nov 05, 2020

BUY
$55.23 - $79.93 $108,195 - $156,582
1,959 Added 13.07%
16,944 $1.32 Million
Q2 2020

Aug 05, 2020

BUY
$30.2 - $56.98 $19,962 - $37,663
661 Added 4.61%
14,985 $833,000
Q1 2020

May 06, 2020

BUY
$24.87 - $38.56 $6,690 - $10,372
269 Added 1.91%
14,324 $424,000
Q4 2019

Feb 07, 2020

BUY
$25.43 - $36.67 $2,746 - $3,960
108 Added 0.77%
14,055 $509,000
Q3 2019

Nov 12, 2019

SELL
$23.0 - $27.97 $13,777 - $16,754
-599 Reduced 4.12%
13,947 $380,000
Q2 2019

Aug 12, 2019

BUY
$22.81 - $28.48 $331,794 - $414,270
14,546 New
14,546 $350,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.